ShermanSI. 2011. Targeted therapies for thyroid tumors. Mod Pathol, 24,Suppl 2:S44–52.
2.
LadensonPW. 2011. Thyroid hormone analogues: ready for prime time. Thyroid, 21:101–102.
3.
AllenMD, NeumannS, GershengornS. 2011. Small molecule thyrotropin receptor agonist activates naturally-occurring TSH-insensitive mutants and reveals their distinct cAMP signal persistence. Thyroid, 21:907–912.
4.
TitusS, NeumannS, ZhengW, SouthallN, MichaelS, KlumppC, YasgarA, ShinnP, ThomasCJ, IngleseJ, GershengornMC, AustinCP. 2008. Quantitative high-throughput screening using a live-cell cAMP assay identifies small-molecule agonists of the TSH receptor. J Biomol Screen, 13:120–127.
5.
NeumannS, RaakaBM, GershengornMC. 2010. Constitutively active thyrotropin and thyrotropin-releasing hormone receptors and their inverse agonists. Methods Enzymol, 485:147–160.
6.
NeumannS, RaakaBM, GershengornMC. 2009. Human TSH receptor ligands as pharmacological probes with potential clinical application. Expert Rev Endocrinol Metab, 4:669.
7.
NeumannS, KleinauG, CostanziS, MooreS, JiangJK, RaakaBM, ThomasCJ, KrauseG, GershengornMC. 2008. A low-molecular-weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism. Endocrinology, 149:5945–5950.
8.
NeumannS, HuangW, TitusS, KrauseG, KleinauG, AlberobelloAT, ZhengW, SouthallNT, IngleseJ, AustinCP, CeliFS, GavrilovaO, ThomasCJ, RaakaBM, GershengornMC. 2009. Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice. Proc Natl Acad Sci U S A, 106:12471–12476.
9.
NeumannS, HuangW, EliseevaE, TitusS, ThomasCJ, GershengornMC. 2010. A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. Endocrinology, 151:3454–3459.
10.
NeumannS, GershengornMC. 2011. Small molecule TSHR agonists and antagonists. Ann Endocrinol (Paris), 72:74–76.
11.
NeumannS, EliseevaE, McCoyJG, NapolitanoG, GiulianiC, MonacoF, HuangW, GershengornMC. 2011. A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor. J Clin Endocrinol Metab, 96:548–554.
12.
MooreS, JaeschkeH, KleinauG, NeumannS, CostanziS, JiangJK, ChildressJ, RaakaBM, ColsonA, PaschkeR, KrauseG, ThomasCJ, GershengornMC. 2006. Evaluation of small-molecule modulators of the luteinizing hormone/choriogonadotropin and thyroid stimulating hormone receptors: structure-activity relationships and selective binding patterns. J Med Chem, 49:3888–3896.
13.
KleinauG, HaasAK, NeumannS, WorthCL, HoyerI, FurkertJ, RutzC, GershengornMC, SchuleinR, KrauseG. 2010. Signaling-sensitive amino acids surround the allosteric ligand binding site of the thyrotropin receptor. FASEB J, 24:2347–2354.
14.
JaschkeH, NeumannS, MooreS, ThomasCJ, ColsonAO, CostanziS, KleinauG, JiangJK, PaschkeR, RaakaBM, KrauseG, GershengornMC. 2006. A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR)J Biol Chem, 281:9841–9844.
15.
HaasAK, KleinauG, HoyerI, NeumannS, FurkertJ, RutzC, SchuleinR, GershengornMC, KrauseG. 2011. Mutations that silence constitutive signaling activity in the allosteric ligand-binding site of the thyrotropin receptor. Cell Mol Life Sci, 68:159–167.
ReinfelderJ, MaschauerS, FossCA, NimmagaddaS, FremontV, WolfV, WeintraubBD, PomperMG, SzkudlinskiMW, KuwertT, PranteO. 2011. Effects of recombinant human thyroid-stimulating hormone superagonists on thyroidal uptake of (18)F-fluorodeoxyglucose and radioiodide. Thyroid, 21:783–792.
18.
SandersJ, AllenF, JeffreysJ, BoltonJ, RichardsT, DepraetereH, NakatakeN, EvansM, KiddieA, PremawardhanaLD, ChirgadzeDY, MiguelRN, BlundellTL, FurmaniakJ, SmithBR. 2005. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist. Thyroid, 15:672–682.
19.
SandersJ, EvansM, BetterleC, SandersP, BhardwajaA, YoungS, RobertsE, WilmotJ, RichardsT, KiddieA, SmallK, PlattH, SummerhayesS, HarrisR, ReeveM, CocoG, ZanchettaR, ChenS, FurmaniakJ, SmithBR. 2008. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity. Thyroid, 18:735–746.
YipJ, LangBH, LoCY. 2011. Changing trend in surgical indication, management for Graves' disease. Am J Surg.
25.
EmersonCH, AndersonAJ, HowardWJ, UtigerRD. 1975. Serum thyroxine and triiodothyronine concentrations during iodide treatment of hyperthyroidism. J Clin Endocrinol Metab, 40:33–36.
26.
HershmanJM. 2004. Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. Best Pract Res Clin Endocrinol Metab, 18:249–265.
27.
EmersonCH, UtigerRD. 1972. Hyperthyroidism and excessive thyrotropin secretion. N Engl J Med, 287:328–333.
28.
GesundheitN, PetrickPA, NissimM, DahlbergPA, DoppmanJL, EmersonCH, BravermanLE, OldfieldEH, WeintraubBD. 1989. Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients. Ann Intern Med, 111:827–835.
